Aids and Society :: HIV Social Issues Health Essays

support and Society Aids and Society The number of newborns infected by erect contagion of the human immunodeficiency virus is increasing as the prevalence of HIV-positive women augment within the United States. It is estimated that while seven thousand HIV-positive women become large(predicate) each year, between one thousand and two thousand of their newborns go away be HIV-positive. This research paper will concent respect on the transmitting of the human immunodeficiency virus from mother to child, the benefits of drugs encumbrance, and whether or not the HIV-screening process of big(predicate) women should remain voluntary or become mandatory. The HIV-virus has proven that it is not a disease to be taken lightly or ignored. I chose this question because I want to be informed about the virus and its rate of vertical transmission so that I will be up to(p) to inform others about such ethical topics Does the baby substantiate rights and should a pregnant women be denied her right to privacy with respect to HIV? info shows that AIDS is now increasing faster among females than males, with women accounting for seven portion of cases in 1985 and nineteen percent in 1995. The incidences of HIV-positive heterosexual women wealthy person rise dramatically over the past decade, and AIDS is now the third lead-in cause of death among women ages twenty-five to forty-four. The one thing that all of these women have in common is that they all are of child bearing age. Consequently, the incidences of HIV-positive newborns have also increased. As mentioned previously, about seven thousand HIV-infected women give consume each year, and about twenty-five percent of their babies are HIV-positive. Maternal transmission accounted for ninety-two percent of all new AIDS cases reported in children in 1994(Davis15). A major breakthrough in drug intervention began in February 1993. The AIDS Clinical Trials Group administered a double-blinded, randomized, placebo-cont rolled study of zidovudine, also known as AST. Four hundred seventy-five women were enrolled in the study. These women were helter-skelter assigned to one of two groups. One group received zidovudine while the other, the control group, received a placebo. The administration of either zidovudine or placebo began in the second trimester of pregnancy and continued through labor. For sextuplet weeks after birth, the babies received the same treatment as the mothers in a syrup form. Because it was a double-blinded study, neither the researchers nor the patients knew who was actually receiving the zidovudine.